Building the Future of Pharmaceutical Manufacturing: A Phased Approach to Dark Factories
Life sciences organizations are navigating a perfect storm: surging global patient demand, compressed drug development lifecycles and relentless margin compression in a highly price-sensitive market....
Read MoreAccelerating Capex Efficiency and Operational Readiness with Digital Twins
Bringing a new life sciences facility online is no longer just a construction milestone — it is a knowledge milestone. Most project delays do not come...
Read MoreDigital Validation for Emerging Life Sciences Companies: Why the Time to Transform Is Earlier Than Ever
The life sciences sector continues to evolve at a rapid pace, driven by accelerated development timelines, heightened regulatory expectations and increasing pressure to operationalize quality from the earliest stages...
Read MoreHuman Factors in Pharma Manufacturing: Beyond Error Prevention
Introduction: Why Human Error is a Failing Root Cause Pharmaceutical manufacturing operates in highly regulated, high-stakes environments where deviations can impact product quality, patient safety,...
Read MoreEmpowering Operational Readiness: How Advanced Technologies Reshape Industry Practices
Operational readiness is a critical milestone for any organization embarking on new projects or processes. Achieving readiness requires more than just meticulous planning; it demands...
Read MoreA Framework for Trust: Understanding the FDA’s AI Risk-Based Credibility Assessment (Part 1 of 3)
Nick Armstrong, Senior Director of Digital Enablement at CAI and co-chair of the ISPE Community of Practice on AI, specializes in the intersection of artificial...
Read More